Actively Recruiting

Phase 2
Age: 18Years - 65Years
All Genders
Healthy Volunteers
NCT07409753

Effects Of Intravenous Oxytocin On Peripheral Sensory Afferents Using Microneurography

Led by Wake Forest University Health Sciences · Updated on 2026-02-13

60

Participants Needed

1

Research Sites

84 weeks

Total Duration

On this page

Sponsors

W

Wake Forest University Health Sciences

Lead Sponsor

N

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if oxytocin reduces pain in a small area of skin after pulses of non-burning heat by changing how nerves in the heated area react to pressing a thin, bendable plastic bristle and a thick, non-bending plastic bristle in adult, healthy participants. The man questions it aims to answer are: Does oxytocin increase the number of times a fiber which normally responds only to the thin bristle fires (sends a signal) after the heat pulses. Does oxytocin raise the number of times a fiber which normally responds only to the thick bristle fires (sends a signal) after the heat pulses. Researchers will compare oxytocin to a placebo (a look-alike substance that contains no drug) to see if oxytocin ABC works to change how nerves react to light touch and painful pressing in an area of sensitized skin. Participants will: Receive an intravenous injection of oxytocin or placebo on one occasion On the same day, a needle will be put near nerve fibers to record their firing before and after a few cycles of short heating of the skin.

CONDITIONS

Official Title

Effects Of Intravenous Oxytocin On Peripheral Sensory Afferents Using Microneurography

Who Can Participate

Age: 18Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to 65 years
  • In good health based on medical, psychiatric, and lab assessments
  • Female participants of child-bearing potential must use highly effective birth control or abstain for at least one full cycle before treatment
  • Normal blood pressure (90-140 mmHg systolic; 50-90 mmHg diastolic) and resting heart rate (45-100 bpm) without medication
  • Proficient in Swedish or English
Not Eligible

You will not qualify if you...

  • Allergy or significant reaction to oxytocin or placebo ingredients
  • Any medical or surgical condition that increases risk or affects study compliance or data quality
  • Women who are pregnant, nursing, or have been pregnant within 2 years
  • Body mass index (BMI) over 30
  • Having neuropathy, chronic pain, diabetes, or daily use of benzodiazepines or pain medications
  • History or current ventricular tachycardia, atrial fibrillation, or prolonged QT interval
  • History or risk of hyponatremia or taking specific medications including diuretics, lithium, antidepressants, or recreational drugs
  • Known latex allergy
  • Substance use disorders or other psychiatric disorders
  • High risk of fainting episodes

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Linköping University

Linköping, Sweden, 58183

Actively Recruiting

Loading map...

Research Team

H

Hakan Olausson, MD, PhD

CONTACT

S

Saad Nagi, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here